Pfizer Discontinued Operations from 2010 to 2026

PFE Stock  EUR 23.32  0.15  0.65%   
Pfizer's Discontinued Operations is increasing over the last several years with very volatile swings. Discontinued Operations is predicted to flatten to about 6.6 M. During the period from 2010 to 2026 Pfizer Inc Discontinued Operations regressed destribution of quarterly values had mean deviationof  1,472,910,969 and mean square error of 5007581.4 T. View All Fundamentals
 
Discontinued Operations  
First Reported
2016-12-31
Previous Quarter
-2 M
Current Value
-2 M
Quarterly Volatility
135.7 M
 
Covid
 
Interest Hikes
Check Pfizer financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pfizer's main balance sheet or income statement drivers, such as Discontinued Operations of 6.6 M, Interest Expense of 3.7 B or Selling General Administrative of 11.2 B, as well as many indicators such as Price To Sales Ratio of 2.16, Dividend Yield of 0.0727 or PTB Ratio of 1.85. Pfizer financial statements analysis is a perfect complement when working with Pfizer Valuation or Volatility modules.
  
This module can also supplement various Pfizer Technical models . Check out the analysis of Pfizer Correlation against competitors.
The Discontinued Operations trend for Pfizer Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Pfizer is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Pfizer's Discontinued Operations Growth Pattern

Below is the plot of the Discontinued Operations of Pfizer Inc over the last few years. It is Pfizer's Discontinued Operations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pfizer's overall financial position and show how it may be relating to other accounts over time.
Discontinued Operations10 Years Trend
Very volatile
   Discontinued Operations   
       Timeline  

Pfizer Discontinued Operations Regression Statistics

Arithmetic Mean885,085,588
Coefficient Of Variation245.04
Mean Deviation1,472,910,969
Median16,000,000
Standard Deviation2,168,814,323
Sample Variance4703755.6T
Range7.8B
R-Value0.04
Mean Square Error5007581.4T
R-Squared0
Significance0.87
Slope18,940,539
Total Sum of Squares75260089.1T

Pfizer Discontinued Operations History

20266.6 M
20256.9 M
2022M
2021-434 M
20202.5 B
20195.3 B
20187.3 B

About Pfizer Financial Statements

Pfizer stakeholders use historical fundamental indicators, such as Pfizer's Discontinued Operations, to determine how well the company is positioned to perform in the future. Although Pfizer investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pfizer's assets and liabilities are reflected in the revenues and expenses on Pfizer's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pfizer Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Discontinued Operations6.9 M6.6 M

Currently Active Assets on Macroaxis

When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Check out the analysis of Pfizer Correlation against competitors.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
It's important to distinguish between Pfizer's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pfizer should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Pfizer's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.